Microbot Medical (MBOT) Cash & Current Investments (2010 - 2026)

Microbot Medical has reported Cash & Current Investments for 17 years, with the latest figure at $69.6 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Current Investments rose 155.86% year-over-year to $69.6 million; the trailing twelve-month figure through Mar 2026 stood at $69.6 million (up 155.86% YoY), and the FY2025 full-year result was $78.6 million, up 1336.78% from the prior year.
• Cash & Current Investments for Q1 2026 stood at $69.6 million, down from $78.6 million in the prior quarter.
• The five-year high for Cash & Current Investments was $80.2 million in Q3 2025, with the low at $2.1 million in Q3 2022.
• Historically, Cash & Current Investments has averaged $20.3 million across 5 years, with a median of $6.4 million in 2023.
• Annual changes were most pronounced in 2022 — Cash & Current Investments slumped 90.91% — and 2025, when it soared 1747.81%.
• Microbot Medical's Cash & Current Investments stood at $2.4 million in 2022, then jumped by 161.15% to $6.4 million in 2023, then retreated by 14.33% to $5.5 million in 2024, then surged by 1336.78% to $78.6 million in 2025, then fell by 11.38% to $69.6 million in 2026.
• The last three Cash & Current Investments figures came in at $69.6 million (Q1 2026), $78.6 million (Q4 2025), and $80.2 million (Q3 2025), per Business Quant data.